Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D Registry

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Chronic Heart Failure 7 Pharmacotherapy HFA Premium Access Heart Failure 2022

ESC 365 is supported by

ESC 365 is supported by